NCT05882045: A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- State
- Completed
- Phase
- Phase 3
- People
- 1,946 taking part
- Started
- 30 May 2023
- Primary completion
- 16 Apr 2026
- Arms
- Retatrutide Dose 1, Retatrutide Dose 2
- Results
- None posted
- 30 May 2023: Trial started
- 31 May 2023: Trial registered
- 14 May 2026: Trial completed